enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dapagliflozin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin

   Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment

3. Which 10 prescription drugs covered under Medicare are ... - AOL

   www.aol.com/10-prescription-drugs-covered-under...

   Farxiga from AstraZeneca AB is used to reduce the risks of diabetes, heart failure and chronic kidney disease. List price in 2023 for a 30-day supply was $556, and the new list price will be $178. ...

4. Medicare can now negotiate prices on these drugs to help ...

   www.aol.com/medicare-now-negotiate-prices-drugs...

   - Jardiance (diabetes; heart failure) - Xarelto (prevention and treatment of blood clots; reduction of risk for patients with coronary or peripheral artery disease) - Januvia (diabetes)

5. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors ...

6. These are the drugs that are getting cheaper under new ...

   www.aol.com/drugs-getting-cheaper-under-medicare...

   Drugs used to treat heart disease, cancer, diabetes, blood clots and more are going to get cheaper, potentially saving money for million of people on Medicare. ... Jardiance, Januvia, and Farxiga ...

7. Factbox-Top Medicare drugs headed for price cuts - AOL

   www.aol.com/news/factbox-top-medicare-drugs...

   Boehringer Ingelheim and Eli Lilly's Jardiance is used to treat type-2 diabetes, heart failure and chronic kidney disease. It cost Medicare $7 billion for 1.6 million patients in the same period ...

8. Empagliflozin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin

   The main efficacy measurement was the time to death from cardiovascular causes or need to be hospitalized for heart failure. [33] Of the individuals who received empagliflozin for an average of about two years, 14% died from cardiovascular causes or were hospitalized for heart failure, compared to 17% of the participants who received the ...

9. Which 10 prescription drug prices are dropping in 2026 after ...

   www.aol.com/10-prescription-drug-prices-dropping...

   Jardiance from Boehringer Ingelheim is used to reduce the risk of heart failure and chronic kidney disease and lower blood sugar. List price last year was $573, 2026 list price will drop 66% to $197.